Imago Biosciences Inc

Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing small molecule product candidates that target lysine-specific demethylase 1, an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago BioSciences serves medical sector in the United States.